ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2

World Health Organization Seroepidemiology Technical Working Group; Maria D. Van Kerkhove; Rebecca Grant; Lorenzo Subissi; Marta Valenciano; Ketevan Glonti; Isabel Bergeri; Polina Brangel; Olivier Le Polain; Hannah Lewis; Anthony Nardone; Richard Pebody; Tasnim Azim; Pushpa Wijesinghe; Lubna Al Ariqi; Linh Vi Le; Joseph Okeibunor; Andrea Vicari; Amen Ben Hamida; Venkatachalam Udhayakumar; Kathleen Gallagher; Vincent Richard; Rahul Arora; Niklas Bobrovitz; Maria Zambon; Christian Drosten; Marion Koopmans; Malik Peiris

doi:10.1111/irv.12870

ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2

World Health Organization Seroepidemiology Technical Working Group, Maria D. Van Kerkhove^*, Rebecca Grant, Lorenzo Subissi, Marta Valenciano, Ketevan Glonti, Isabel Bergeri, Polina Brangel, Olivier Le Polain, Hannah Lewis, Anthony Nardone, Richard Pebody, Tasnim Azim, Pushpa Wijesinghe, Lubna Al Ariqi, Linh Vi Le, Joseph Okeibunor, Andrea Vicari, Amen Ben Hamida, Venkatachalam UdhayakumarKathleen Gallagher, Vincent Richard, Rahul Arora, Niklas Bobrovitz, Maria Zambon, Christian Drosten, Marion Koopmans, Malik Peiris

^*Corresponding author for this work

Divisional Office

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

9 Downloads (Pure)

Abstract

Well-designed population-based seroepidemiologic studies can be used to refine estimates of infection severity and transmission, and are therefore an important component of epidemic surveillance. However, the interpretation of the results of seroepidemiologic studies for SARS-CoV-2 has been hampered to date principally by heterogeneity in the quality of the reporting of the results of the study and a lack of standardized methods and reporting. We provide here the ROSES-S: Reporting of Seroepidemiologic studies—SARS-CoV-2. This is an updated checklist of 22 items that should be included in the reporting of all SARS-CoV-2 seroepidemiologic studies, irrespective of study design.

Original language	English
Pages (from-to)	561-568
Number of pages	8
Journal	Influenza and other Respiratory Viruses
Volume	15
Issue number	5
Early online date	26 Jun 2021
DOIs	https://doi.org/10.1111/irv.12870
Publication status	Published - Sept 2021

Bibliographical note

Funding Information: The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors

Open Access: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Publisher Copyright: © 2021 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.

Citation: World Health Organization Seroepidemiology Technical Working Group. ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2. Influenza Other Respi Viruses. 2021; 15: 561– 568.

DOI: https://doi.org/10.1111/irv.12870

Keywords

SARS-CoV-2
emerging
infectious diseases
seroepidemiologic Studies

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/irv.12870Licence: CC BY

WorldHealthOrganizationSeroepidemiologyTechnicalWorkingGroup2021ROSES-SStatementFromTheWorldHealthOrganizationInfluenzaOtherRespiVirusesFinal published version, 233 KBLicence: CC BY

Cite this

World Health Organization Seroepidemiology Technical Working Group, Van Kerkhove, M. D., Grant, R., Subissi, L., Valenciano, M., Glonti, K., Bergeri, I., Brangel, P., Le Polain, O., Lewis, H., Nardone, A., Pebody, R., Azim, T., Wijesinghe, P., Al Ariqi, L., Le, L. V., Okeibunor, J., Vicari, A., Hamida, A. B., ... Peiris, M. (2021). ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2. Influenza and other Respiratory Viruses, 15(5), 561-568. https://doi.org/10.1111/irv.12870

@article{e089671142634c77b00effa9c3f8bc2c,

title = "ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2",

abstract = "Well-designed population-based seroepidemiologic studies can be used to refine estimates of infection severity and transmission, and are therefore an important component of epidemic surveillance. However, the interpretation of the results of seroepidemiologic studies for SARS-CoV-2 has been hampered to date principally by heterogeneity in the quality of the reporting of the results of the study and a lack of standardized methods and reporting. We provide here the ROSES-S: Reporting of Seroepidemiologic studies—SARS-CoV-2. This is an updated checklist of 22 items that should be included in the reporting of all SARS-CoV-2 seroepidemiologic studies, irrespective of study design.",

keywords = "SARS-CoV-2, emerging, infectious diseases, seroepidemiologic Studies",

author = "{World Health Organization Seroepidemiology Technical Working Group} and {Van Kerkhove}, {Maria D.} and Rebecca Grant and Lorenzo Subissi and Marta Valenciano and Ketevan Glonti and Isabel Bergeri and Polina Brangel and {Le Polain}, Olivier and Hannah Lewis and Anthony Nardone and Richard Pebody and Tasnim Azim and Pushpa Wijesinghe and {Al Ariqi}, Lubna and Le, {Linh Vi} and Joseph Okeibunor and Andrea Vicari and Hamida, {Amen Ben} and Venkatachalam Udhayakumar and Kathleen Gallagher and Vincent Richard and Rahul Arora and Niklas Bobrovitz and Maria Zambon and Christian Drosten and Marion Koopmans and Malik Peiris",

note = "Funding Information: The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors Open Access: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Publisher Copyright: {\textcopyright} 2021 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd. Citation: World Health Organization Seroepidemiology Technical Working Group. ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2. Influenza Other Respi Viruses. 2021; 15: 561– 568. DOI: https://doi.org/10.1111/irv.12870 ",

year = "2021",

month = sep,

doi = "10.1111/irv.12870",

language = "English",

volume = "15",

pages = "561--568",

journal = "Influenza and other Respiratory Viruses",

issn = "1750-2640",

publisher = "Wiley Open Access",

number = "5",

}

World Health Organization Seroepidemiology Technical Working Group, Van Kerkhove, MD, Grant, R, Subissi, L, Valenciano, M, Glonti, K, Bergeri, I, Brangel, P, Le Polain, O, Lewis, H, Nardone, A, Pebody, R, Azim, T, Wijesinghe, P, Al Ariqi, L, Le, LV, Okeibunor, J, Vicari, A, Hamida, AB, Udhayakumar, V, Gallagher, K, Richard, V, Arora, R, Bobrovitz, N, Zambon, M, Drosten, C, Koopmans, M & Peiris, M 2021, 'ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2', Influenza and other Respiratory Viruses, vol. 15, no. 5, pp. 561-568. https://doi.org/10.1111/irv.12870

ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2. / World Health Organization Seroepidemiology Technical Working Group; Van Kerkhove, Maria D.; Grant, Rebecca et al.
In: Influenza and other Respiratory Viruses, Vol. 15, No. 5, 09.2021, p. 561-568.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - ROSES-S

T2 - Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2

AU - World Health Organization Seroepidemiology Technical Working Group

AU - Van Kerkhove, Maria D.

AU - Grant, Rebecca

AU - Subissi, Lorenzo

AU - Valenciano, Marta

AU - Glonti, Ketevan

AU - Bergeri, Isabel

AU - Brangel, Polina

AU - Le Polain, Olivier

AU - Lewis, Hannah

AU - Nardone, Anthony

AU - Pebody, Richard

AU - Azim, Tasnim

AU - Wijesinghe, Pushpa

AU - Al Ariqi, Lubna

AU - Le, Linh Vi

AU - Okeibunor, Joseph

AU - Vicari, Andrea

AU - Hamida, Amen Ben

AU - Udhayakumar, Venkatachalam

AU - Gallagher, Kathleen

AU - Richard, Vincent

AU - Arora, Rahul

AU - Bobrovitz, Niklas

AU - Zambon, Maria

AU - Drosten, Christian

AU - Koopmans, Marion

AU - Peiris, Malik

N1 - Funding Information: The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors Open Access: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Publisher Copyright: © 2021 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd. Citation: World Health Organization Seroepidemiology Technical Working Group. ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2. Influenza Other Respi Viruses. 2021; 15: 561– 568. DOI: https://doi.org/10.1111/irv.12870

PY - 2021/9

Y1 - 2021/9

N2 - Well-designed population-based seroepidemiologic studies can be used to refine estimates of infection severity and transmission, and are therefore an important component of epidemic surveillance. However, the interpretation of the results of seroepidemiologic studies for SARS-CoV-2 has been hampered to date principally by heterogeneity in the quality of the reporting of the results of the study and a lack of standardized methods and reporting. We provide here the ROSES-S: Reporting of Seroepidemiologic studies—SARS-CoV-2. This is an updated checklist of 22 items that should be included in the reporting of all SARS-CoV-2 seroepidemiologic studies, irrespective of study design.

AB - Well-designed population-based seroepidemiologic studies can be used to refine estimates of infection severity and transmission, and are therefore an important component of epidemic surveillance. However, the interpretation of the results of seroepidemiologic studies for SARS-CoV-2 has been hampered to date principally by heterogeneity in the quality of the reporting of the results of the study and a lack of standardized methods and reporting. We provide here the ROSES-S: Reporting of Seroepidemiologic studies—SARS-CoV-2. This is an updated checklist of 22 items that should be included in the reporting of all SARS-CoV-2 seroepidemiologic studies, irrespective of study design.

KW - SARS-CoV-2

KW - emerging

KW - infectious diseases

KW - seroepidemiologic Studies

UR - http://www.scopus.com/inward/record.url?scp=85108529666&partnerID=8YFLogxK

U2 - 10.1111/irv.12870

DO - 10.1111/irv.12870

M3 - Article

C2 - 34173715

AN - SCOPUS:85108529666

SN - 1750-2640

VL - 15

SP - 561

EP - 568

JO - Influenza and other Respiratory Viruses

JF - Influenza and other Respiratory Viruses

IS - 5

ER -

ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this